Benefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine

N Engl J Med. 2023 Mar 30;388(13):1233-1239. doi: 10.1056/NEJMsr2214184.

Authors

Peter Lee¹, Sebastien Bubeck¹, Joseph Petro¹

Affiliation

¹ From Microsoft Research, Redmond, WA (P.L., S.B.); and Nuance Communications, Burlington, MA (J.P.).

PMID: 36988602
DOI: 10.1056/NEJMsr2214184

No abstract available

MeSH terms

Artificial Intelligence*
Humans
Medicine*
Risk Assessment